"We are pleased the court has rejected the compounders' attempts to undermine FDA's data-based decision that the shortage" of semaglutide is resolved, said Steve Benz, Novo Nordisk's corporate vice ...

A judge denied compounders' request to keep making off-brand Wegovy and Ozempic after the FDA removed semaglutide from its shortage list.

Novo Nordisk's collaboration with telehealth providers offers semaglutide at $499/month, enhancing access for self-paying ...

A federal court in Texas has bolstered Novo Nordisk’s efforts to limit the production and sale of compounded versions of its GLP-1 drugs, Wegovy and Ozempic. Here are five notes: ...

They are large molecule drugs, so complex in structure and must be ... manner as these market-leading products. Novo Nordisk offers a pill version of semaglutide, called Rybelsus, for type 2 ...

Novo Nordisk on Wednesday reported a better-than-expected rise in net profit but lowered its full-year sales growth forecast.

One day after WeightWatchers said that it would file for bankruptcy, weight-loss drug giant Novo Nordisk’s outlook is brightening. Novo Nordisk, the Danish company that produces the semaglutide ...

Novo Nordisk's (NVO) investors are worried its ... showed 80 million prescriptions for copycat semaglutide were filled in the past year. That, Jørgensen said, is why the company missed its ...

Obesity drug developers Verve Therapeutics (VERV), Structure Therapeutics ... Wegovy is going nowhere. Moreover, Novo Nordisk's (NVO) oral semaglutide (approved as Rybelsus for diabetes) could ...

They are large molecule drugs, so complex in structure and must be administered by ... operates in the same manner as these market-leading products. Novo Nordisk offers a pill version of semaglutide, ...